ANAB
USDAnaptysBio Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$35.970
Максимум
$36.500
Минимум
$34.595
Объем
0.76M
Фундаментальные показатели компании
Рыночная капитализация
971.8M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
0.52M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update
Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on track for Nov./Dec.
Anaptys Announces Participation in November Investor Conferences
SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president
Stifel Maintains Buy on AnaptysBio, Raises Price Target to $80
Stifel analyst Alex Thompson maintains AnaptysBio with a Buy and raises the price target from $55 to $80.
Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
New data reinforce rosnilimab's efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced therapy, including
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.